These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2937009)

  • 41. Within-individual variation in steady state plasma levels of different neuroleptics and prolactin.
    McCreadie RG; Mackie M; Wiles DH; Jorgensen A; Hansen V; Menzies C
    Br J Psychiatry; 1984 Jun; 144():625-9. PubMed ID: 6146373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.
    Gramsch C; Emrich HM; John S; Haas S; Beckmann H; Zaudig M; von Zerssen D
    J Neural Transm; 1984; 59(2):133-41. PubMed ID: 6144724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.
    de Koning P; de Vries MH
    Br J Clin Pharmacol; 1995 Jan; 39(1):7-14. PubMed ID: 7756102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid control of psychotic excitement states with intramuscular haloperidol.
    Sangiovanni F; Taylor MA; Abrams R; Gaztanaga P
    Am J Psychiatry; 1973 Oct; 130(10):1155-6. PubMed ID: 4728914
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder.
    Weizman R; Gil-Ad I; Hermesh H; Munitz H; Laron Z
    Clin Neuropharmacol; 1990 Aug; 13(4):297-302. PubMed ID: 2208181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating pituitary hormones in primary aldosteronism.
    Hsieh BS; Chang CC; Chen FW; Chen WY; Yen TS
    Taiwan Yi Xue Hui Za Zhi; 1983 May; 82(5):644-51. PubMed ID: 6313848
    [No Abstract]   [Full Text] [Related]  

  • 47. The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol.
    Cookson JC; Moult PJ; Wiles D; Besser GM
    Psychol Med; 1983 May; 13(2):279-85. PubMed ID: 6878514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.
    Aravagiri M; Marder SR; Van Putten T; Marshall BD
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):373-81. PubMed ID: 7987490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outpatient titration with intramuscular haloperidol as an alternative to psychiatric hospitalization.
    Ingall MA; Farber BL; Kuppe JV; Silveira AP
    R I Med J (1976); 1979 Nov; 62(11):437-42. PubMed ID: 293841
    [No Abstract]   [Full Text] [Related]  

  • 50. Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients.
    Schulz SC; van Kammen DP; Pickar D; Cohen MR; Naber D
    Psychiatry Res; 1982 Oct; 7(2):171-8. PubMed ID: 6292981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Value of pharmacokinetic data during the treatment of psychoses with haloperidol].
    Zarifian E; Cottereau MJ; Cuche H; Lôo H; Deniker P
    Encephale; 1979; 5(3):197-203. PubMed ID: 487991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men.
    Rubin RT; Hays SE
    Psychopharmacology (Berl); 1979 Mar; 61(1):17-24. PubMed ID: 108715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haloperidol plasma level monitoring in pediatric patients.
    Morselli PL; Bianchetti G; Durand G; Le Heuzey MF; Zarifian E; Dugas M
    Ther Drug Monit; 1979; 1(1):35-46. PubMed ID: 553330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. beta-Endorphin: analgesic and hormonal effects in humans.
    Foley KM; Kourides IA; Inturrisi CE; Kaiko RF; Zaroulis CG; Posner JB; Houde RW; Li CH
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5377-81. PubMed ID: 291954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Endorphins of the gamma type in the treatment of schizophrenic psychoses].
    Verhoeven WM; Van Ree JM
    Acta Psychiatr Belg; 1984; 84(2):160-72. PubMed ID: 6204507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuroendocrine effects of caffeine in normal subjects.
    Spindel ER; Wurtman RJ; McCall A; Carr DB; Conlay L; Griffith L; Arnold MA
    Clin Pharmacol Ther; 1984 Sep; 36(3):402-7. PubMed ID: 6467801
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting serum haloperidol level assessed by longitudinal therapeutic monitoring.
    Fukuda R
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1299-318. PubMed ID: 11125855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.